3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the...
Read moreThe investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total flo...
Read more3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.
Read more3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to...
Read more3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.
Read more3P se ocupará de la fabricación cGMP de Isunakinra, un medicamento contra tumores sólidos, que se encuentra en fase I/II de desarrollo en pacientes en EEUU
Read moreHan firmado un convenio para favorecer la transformación digital y la formación de profesionales enfocados a la industria farmacéutica.
Read moreLas empresas biotecnológicas Invizius y 3P Biopharmaceuticals colaboran en una tecnología innovadora para los pacientes que se someten a hemodiálisis y sufren de enfermedades cardiovasculares
Read more3P Biopharmaceuticals, compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo normas de correcta fabricación (cGMPs) de medicamentos biológicos y productos de...
Read moreSe trata de un profesional con dilatada experiencia en empresas de biotecnología
Read moreWe are looking forward to participating in BioPharm America Digital during the week of September 21–24.
Read moreEs un profesional con dilatada experiencia en el sector financiero y se une a 3P para impulsar el crecimiento de la compañía
Read more